GL1X · GenesisL1 explorer

Research workbench

Leg region of a complex of igf-I with the ectodomain of a hybrid insulin receptor / type 1 insulin-like growth factor receptor

Analyse Leg region of a complex of igf-I with the ectodomain of a hybrid insulin… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7S8V
Type
protein
Length
782 residues
Chains
2
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Insulin-like growth factor 1 receptor; Insulin receptor
EC
2.7.10.1
UniProt
P08069, P06213
Ligands
NAG, BMA
Pockets
10 · best druggability 0.77

Structure

electron microscopy · 2 distinct chains · 9% helix, 35% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInsulin-like growth factor 1 receptor (EC 2.7.10.1)protein26411% helix, 36% strandP08069
BInsulin receptor (EC 2.7.10.1)protein5188% helix, 35% strandP06213

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 11 copies · chains A, B
  • BMA · beta-D-mannopyranose · sugar

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17110.770.8188empty
26910.680.7671empty
35510.670.7851empty
42180.580.8034NAG
51730.490.7724empty

Interfaces

1 interface between chains.

  • A–B · 1789 Ų buried · 21 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 17 disulfide, 8 glycan (disulfide, N-glycosylation).

Compared structures

  • 7S8V · Leg region of a complex of IGF-I with the ectodomain of a hybrid insulin receptor / type… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.